CG
WST icon

Corundum Group’s West Pharmaceutical WST Stock Holding History

Corundum Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252K Buy
+701
New +$214K 0.07% 98
2026
Q1 		– Sell
-851
Closed -$234K – 121
2025
Q4 		$234K Buy
+851
New +$233K 0.08% 107

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Corundum Group's WST Position: Q2 2026 in Review

Corundum Group opened a new position in West Pharmaceutical (WST) in Q2 2026: 701 shares worth $252K. The stake represents 0.07% of the portfolio and ranks #98 among its holdings. This is a return to the name: Corundum Group previously reported a position in WST as recently as Q4 2025.

Corundum Group first reported a position in WST in Q4 2025 and has held it in 2 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Corundum Group held 701 shares of West Pharmaceutical worth $252K as of Q2 2026.
  • West Pharmaceutical was a new Corundum Group position in Q2 2026.
  • West Pharmaceutical made up 0.07% of Corundum Group's portfolio in Q2 2026, its #98 holding.
  • Corundum Group first reported a position in West Pharmaceutical in Q4 2025 and has held it in 2 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Corundum Group's 13F filing for Q2 2026, filed 7 Aug 2026.